Safety of Arthritis Drugs, Day 2, Part 3

Committee members heard public comments made by representatives of arthritis-related and consumer organizations, as well as the general… read more

Committee members heard public comments made by representatives of arthritis-related and consumer organizations, as well as the general public, on the safety of various medications designed to treat arthritis, the FDA testing and approval process, their experiences with the medications, and the state of the pharmaceutical industry. 

A joint meeting of the Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees held a forum on the safety of “COX-2” inhibitors. The function of the advisory committee was to provide advice and recommendations to the FDA on regulatory issues. close

People in this video

More People

Hosting Organization

More Videos From

Safety of Arthritis Drugs, Day 2,

More Videos
More information about

Safety of Arthritis Drugs, Day 2, Part 3

85 Views
Program ID:
185588-3
Category:
Public Affairs Event
Format:
Forum
Location:
Gaithersburg, Maryland, United States
First Aired:
Feb 18, 2005
Last Aired:
Feb 24, 2005

Airing Details

  • Feb 18, 2005 | 4:04pm EST | C-SPAN 2
  • Feb 24, 2005 | 1:44pm EST | C-SPAN 2